Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-05-01 @ 1:45 AM
Study NCT ID:
NCT05253066
Status:
UNKNOWN
Last Update Posted:
2022-02-23
First Post:
2022-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Sponsor:
Shengjing Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MUKDEN5
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None